Copioumed AAMI 3 Surgical Gown
Copioumed International, Inc. · Decision date Feb 26, 2026
What did the FDA decide?
FDA records K251860 as a 510(k) premarket notification, with a decision dated Feb 26, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Feb 26, 2026
Regulatory record facts
- Identifier
- K251860
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Copioumed International, Inc.
- Product code
- FYA
- Decision code
- SESE
- Decision date
- Feb 26, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Gown, Surgical.
- Applicant
- Copioumed International, Inc.
- Product code
- FYA
- FDA device class
- 2
FDA decision timeline
K251860 received
Application receipt date recorded by FDA.
K251860 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code FYA
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Principle & Will Co., Ltd. | 510(k) clearance | Aug 26, 2026 | FDA | |
| Yadu Medical (Henan) Co., Ltd. | 510(k) clearance | Aug 7, 2026 | FDA | |
| New York Embroidery Studio | 510(k) clearance | Jul 10, 2026 | FDA | |
| New York Embroidery Studio (NYES) | 510(k) clearance | Jun 4, 2026 | FDA | |
| Hindernis DE Mexico, S.A.P.I. DE C.V. | 510(k) clearance | May 12, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Copioumed International, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Taipei City
Sources and methodology
- Original FDA record: K251860
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


